Kronos Bio (KRON – Research Report) received a Hold rating and price target from TD Cowen analyst Tyler Van Buren yesterday. The ...
Hosted on MSN10h
TD Cowen Downgrades Syros Pharmaceuticals (SYRS)Fintel reports that on November 13, 2024, TD Cowen downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...
Shares of Coty (NYSE:COTY) traded lower in pre-market trading on Wednesday after TD Cowen analysts downgraded the beauty ...
We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...
TD Cowen lowered the firm’s price target on Novavax (NVAX) to $9 from $14 and keeps a Hold rating on the shares. The firm said the FDA lifted its clinical hold on its COVID/flu combo and ...
Chris Krueger, MD, TD Cowen Washington Research Group, shares his thoughts on Trump’s policies when he takes office again in ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.33% of ...
Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...
Shares of investment management firm Onex rose Monday after TD Cowen upgraded the company's outlook on the back of its strong portfolio performance and fundraising. Shares recently traded 6.1% higher ...
TD Cowen on potential opportunities in Canadian equities. The potential impact of Canadian mortgage resets in 2025. Why demographic uncertainty could be a major challenge for the Canadian economy.
As America’s aging Baby Boomers start to crack open their nest eggs in retirement, there’s speculation that they will use the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback